Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Long-term PPI use may cause serious hypomagnesemiaU.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Rinse and spit away preterm birth risk Mouthwash is good for more than just gums, study shows Peak experience: Climbing a fundraising mountain Pharmacists not happy with Nunavut's remote dispensing "plan" Territory looks at bypassing community pharmacy with tele-pharmacist counselling and technicians managing drug distribution. New drug fights C. diff with fewer recurrences Question remains about whether treatment period should be extended Cardiology | Drink to your health When patient privacy was lip service A lot of what used to go on in psychiatry’s inpatient wards was there for all to see and hear LETTER: Online ‘data clouds’ offer a brighter future for EMRs? Osteoporosis | Canadian study confirms link between bisphosphonates and fracture risk First Previous 2024 2025 2026 2027 2028 Next Last
